6/3/2025Innovent's IBI343 Shows Promise in Advanced Pancreatic Cancer

6/3/2025LongBio Secures Over CNY 200M in Series C Financing

6/3/2025Neowise Licenses TCR Candidate to BeiGene for Off-the-Shelf Cell Thera...

6/3/2025Hanx Biopharma Files for Hong Kong IPO to Advance Innovative Cancer Th...

6/2/2025Mabwell's Mailisheng Injection Gains Chinese Approval for Chemotherapy...

6/2/2025BioNTech's China-Origin Immunotherapy at Center of $11.1B Deal with BM...

6/2/2025Regeneron Licenses Hansoh's Dual GLP-1/GIP Receptor Agonist to Bolster...

6/2/2025OnCusp Unveils Promising Initial Results from First-in-Human Trial of ...

6/2/2025VelaVigo Expands Global Footprint with Strategic U.S. Biotech Collabor...

6/2/2025ArkBio's AK3280 Shows Significant Phase II Efficacy in IPF

6/2/2025BeiGene Redomiciles to Switzerland and Transitions to BeOne Medicines

5/31/2025Recent Official and Executive Moves

5/31/2025China Approves First Homegrown Nine-Valent HPV Vaccine

5/31/2025Cancer Vaccine Trials in China and the U.S. (2014–2024): A Decade of ...

5/31/2025China's Breakthru Weight-Loss Drug Makes Landmark Debut in NEJM

5/31/2025Hengrui Medicine Gains NMPA Approval for Three New Cancer Therapies

5/31/2025Hansoh Receives NMPA Approval for Clinical Trials of Three Innovative ...

5/31/2025China Grants Conditional Approval to Zymeworks' Zanidatamab for HER2-P...

5/31/2025NMPA Issues New Regulations on Experimental Research of Narcotic and P...

5/31/2025NMPA Reopens Comment on Draft Announcement for Strengthening Oversight...

5/31/2025CSPC Eyes $5B in Licensing Deals for EGFR-ADC and Innovative Therapies

5/31/2025Astellas Enters Exclusive License Agreement with Evopoint Biosciences ...

5/31/2025Ivonescimab Hits Key Milestone in Phase III HARMONi Trial for EGFR-Mut...

5/31/2025Former CFDA Commissioner Bi Jingquan Under Investigation for Serious ...

5/29/2025First Patient Dosed in YK012 Trial -The World's First TCE Therapy for ...

5/29/2025CDE Solicits Comments on Draft Technical Considerations for NMR Studi...

5/29/2025CDE Issues Guideline on Production Site Change Research for Licensed B...

5/29/2025CDE Launches “Starlight Plan” to Encourage Pediatric Antitumor Drug ...

5/29/2025CDE Issues Guideline on Safety Assessment and Reporting in Pediatric D...

5/29/2025AusperBio Secures $50M in Series B+ Financing

Page:9/54 Total number of articles:1607: [First][<<] [7] [8] [9] [10] [11] [>>] [End]